News
15h
GlobalData on MSNInsmed wins FDA approval for future blockbuster Brinsupri
Insmed’s drug Brinsupri (brensocatib) has landed a double regulatory landmark win, becoming both the first marketed ...
15h
Pharmaceutical Technology on MSNPureTech forms respiratory spin-off Celea to advance deuterated pirfenidone
PureTech's latest spinoff Celea Therapeutics was created to progress the former's lead respiratory IPF programme, ...
13h
Air Force Technology on MSNDARPA refine EW tactics with an RF battlespace emulator
DARPA has developed a radio frequency test range to refine to help the US simulate complex RF engagements for modern EW ...
Artificial intelligence is showing promise in improving the detection and management of idiopathic pulmonary fibrosis (IPF), ...
10h
GlobalData on MSNElicio’s peptide cancer vaccine shows survival benefit in Phase I trial
Elicio's mKRAS-targeting cancer vaccine reduced the risk of death by 77% by activating the anti-tumour mechanisms of key ...
7h
East Idaho News on MSNAmazon just made it easier to order fresh food
Amazon is rolling out same-day delivery of fresh food to more than 1,000 cities, a sign that it’s finally finding success ...
21h
Startups.co.uk on MSNPandora cyber attack highlights growing threat to ecommerce
As cyber attacks on major retailers like Pandora continue to hit headlines, experts are urging ecommerce businesses to step ...
10h
GlobalData on MSNResponse’s post-GLP-1RA drug reduces weight rebound in Phase II
Response is also considering running trials of the weight management drug RDX-002 in combination with GLP-1RA therapies.
Customers can use the app to order food, beverages, personal care products, cleaning supplies and more from both the retailer ...
The government has announced feed-in tariffs, its revised Power Development Plan 8 (PDP 8) and other policies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results